Breaking News

Wednesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Tesla ineligible for S&P 500 ESG Index inclusion, S&P announces » 11:28
05/18/22
05/18
11:28
05/18/22
11:28
TSLA

Tesla

$743.02 /

-18.83 (-2.47%)

, BRK.A

Berkshire Hathaway

$465,000.00 /

-4000 (-0.85%)

, JNJ

Johnson & Johnson

$177.29 /

-1.58 (-0.88%)

, FB

Meta Platforms

$198.21 /

-4.495 (-2.22%)

Margaret Dorn, Senior…

Margaret Dorn, Senior Director, Head of ESG Indices, North America at S&P Dow Jones Indices, stated in a blog post dated May 17: "It is that time of year yet again: the seasons are changing, spring is in the air and the S&P 500 ESG Index has undergone its fourth annual rebalance. Just as it has in years past, the changes of the 2022 rebalance reflect the delicate balancing act of providing for broad-based market exposure but with meaningful and measurable sustainability-focused enhancements... one familiar name may stick out as being absent from that list: Tesla. Tesla was ineligible for index inclusion due to its low S&P DJI ESG Score, which fell in the bottom 25% of its global GICS industry group peers. It joins Berkshire Hathaway, Johnson & Johnson and Meta, which have once again met the index methodology's chopping block... But, how can a company whose self-declared mission is to 'accelerate the world's transition to sustainable energy' not make the cut in an ESG index? First and foremost, the GICS industry group in which Tesla is assessed - Automobiles & Components - experienced an overall increase in its average S&P DJI ESG Score. So, while Tesla's S&P DJI ESG Score has remained fairly stable year-over-year, it was pushed further down the ranks relative to its global industry group peers. A few of the factors contributing to its 2021 S&P DJI ESG Score were a decline in criteria level scores related to Tesla's (lack of) low carbon strategy and codes of business conduct. In addition, a Media and Stakeholder Analysis, a process that seeks to identify a company's current and potential future exposure to risks stemming from its involvement in a controversial incident, identified two separate events centered around claims of racial discrimination and poor working conditions at Tesla's Fremont factory, as well as its handling of the NHTSA investigation after multiple deaths and injuries were linked to its autopilot vehicles. Both of these events had a negative impact on the company's S&P DJI ESG Score at the criteria level, and subsequently its overall score. While Tesla may be playing its part in taking fuel-powered cars off the road, it has fallen behind its peers when examined through a wider ESG lens." Reference Link

ShowHide Related Items >><<
TSLA Tesla
$743.02 /

-18.83 (-2.47%)

JNJ Johnson & Johnson
$177.29 /

-1.58 (-0.88%)

FB Meta Platforms
$198.21 /

-4.495 (-2.22%)

BRK.A Berkshire Hathaway
$465,000.00 /

-4000 (-0.85%)

TSLA Tesla
$743.02 /

-18.83 (-2.47%)

05/18/22 Piper Sandler
Tesla price target lowered to $1,035 from $1,260 at Piper Sandler
05/17/22 Tudor Pickering
Tesla upgraded to Hold from Sell at Tudor Pickering
05/17/22 Wedbush
Tesla shares likely to be under pressure again Tuesday, says Wedbush
05/17/22 Morgan Stanley
Rivian Automotive price target lowered to $60 from $85 at Morgan Stanley
BRK.A Berkshire Hathaway
$465,000.00 /

-4000 (-0.85%)

05/01/22 Keefe Bruyette
Berkshire price target lowered to $560,000 from $565,000 at Keefe Bruyette
04/20/22 Keefe Bruyette
Alleghany downgraded to Market Perform from Outperform at Keefe Bruyette
04/19/22 JMP Securities
Alleghany downgraded to Market Perform from Outperform at JMP Securities
03/21/22 Keefe Bruyette
Alleghany complexity makes other bids unlikely, says Keefe Bruyette
JNJ Johnson & Johnson
$177.29 /

-1.58 (-0.88%)

05/17/22 BofA
Teva upgraded to Neutral at BofA on potential opioid deal upside
05/17/22 Citi
Johnson & Johnson price target lowered to $205 from $210 at Citi
04/29/22 Chardan
Emergent BioSolutions price target lowered to $65 from $75 at Chardan
04/20/22 Credit Suisse
Johnson & Johnson price target raised to $205 from $200 at Credit Suisse
FB Meta Platforms
$198.21 /

-4.495 (-2.22%)

05/18/22 Guggenheim
Meta Platforms price target lowered to $250 from $275 at Guggenheim
05/16/22 Morgan Stanley
Morgan Stanley 'even more encouraged' by Meta's more conservative hiring
04/28/22 MKM Partners
Meta Platforms price target lowered to $295 from $315 at MKM Partners
04/28/22 Evercore ISI
Meta Platforms price target lowered to $325 from $350 at Evercore ISI
TSLA Tesla
$743.02 /

-18.83 (-2.47%)

JNJ Johnson & Johnson
$177.29 /

-1.58 (-0.88%)

FB Meta Platforms
$198.21 /

-4.495 (-2.22%)

BRK.A Berkshire Hathaway
$465,000.00 /

-4000 (-0.85%)

TSLA Tesla
$743.02 /

-18.83 (-2.47%)

JNJ Johnson & Johnson
$177.29 /

-1.58 (-0.88%)

FB Meta Platforms
$198.21 /

-4.495 (-2.22%)

BRK.A Berkshire Hathaway
$465,000.00 /

-4000 (-0.85%)

TSLA Tesla
$743.02 /

-18.83 (-2.47%)

JNJ Johnson & Johnson
$177.29 /

-1.58 (-0.88%)

FB Meta Platforms
$198.21 /

-4.495 (-2.22%)

BRK.A Berkshire Hathaway
$465,000.00 /

-4000 (-0.85%)

TSLA Tesla
$743.02 /

-18.83 (-2.47%)

JNJ Johnson & Johnson
$177.29 /

-1.58 (-0.88%)

FB Meta Platforms
$198.21 /

-4.495 (-2.22%)

Tuesday
Upgrade
Teva upgraded to Neutral at BofA on potential opioid deal upside » 09:25
05/17/22
05/17
09:25
05/17/22
09:25
TEVA

Teva

$7.91 /

+0.145 (+1.87%)

, JNJ

Johnson & Johnson

$178.04 /

+1.18 (+0.67%)

As previously reported,…

As previously reported, BofA analyst Jason Gerberry upgraded Teva (TEVA) to Neutral from Underperform with an unchanged price target of $9 based on both valuation and what he sees as an improved risk/reward. His thesis has generally centered around unpredictable litigation outcomes, mainly related to opioids cases, but he believes recent settlements and progress of others like Johnson & Johnson (JNJ) toward a global opioid accord and reports that Teva may be closer to a global opioid deal lets him see a potential path to upside if the deal can get done in 2022. While he has also been critical of the company's lower quality EBITDA trajectory, he "concedes" that the company has a better new product roster for 2023-24, Gerberry added.

ShowHide Related Items >><<
TEVA Teva
$7.91 /

+0.145 (+1.87%)

JNJ Johnson & Johnson
$178.04 /

+1.18 (+0.67%)

TEVA Teva
$7.91 /

+0.145 (+1.87%)

05/17/22 BofA
Teva upgraded to Neutral from Underperform at BofA
05/04/22 Piper Sandler
Teva downgraded to Underweight from Neutral at Piper Sandler
04/05/22 Barclays
Teva upgraded to Overweight from Equal Weight at Barclays
03/25/22 Bernstein
Teva upgraded to Outperform from Market Perform at Bernstein
JNJ Johnson & Johnson
$178.04 /

+1.18 (+0.67%)

05/17/22 Citi
Johnson & Johnson price target lowered to $205 from $210 at Citi
04/29/22 Chardan
Emergent BioSolutions price target lowered to $65 from $75 at Chardan
04/20/22 Credit Suisse
Johnson & Johnson price target raised to $205 from $200 at Credit Suisse
04/20/22 Citi
Johnson & Johnson price target raised to $210 from $203 at Citi
TEVA Teva
$7.91 /

+0.145 (+1.87%)

JNJ Johnson & Johnson
$178.04 /

+1.18 (+0.67%)

TEVA Teva
$7.91 /

+0.145 (+1.87%)

JNJ Johnson & Johnson
$178.04 /

+1.18 (+0.67%)

TEVA Teva
$7.91 /

+0.145 (+1.87%)

JNJ Johnson & Johnson
$178.04 /

+1.18 (+0.67%)

TEVA Teva
$7.91 /

+0.145 (+1.87%)

JNJ Johnson & Johnson
$178.04 /

+1.18 (+0.67%)

Recommendations
Johnson & Johnson price target lowered to $205 from $210 at Citi » 06:26
05/17/22
05/17
06:26
05/17/22
06:26
JNJ

Johnson & Johnson

$178.04 /

+1.18 (+0.67%)

Citi analyst Joanne…

Citi analyst Joanne Wuensch lowered the firm's price target on Johnson & Johnson to $205 from $210 and keeps a Buy rating on the shares. Market multiples are contracting due to higher inflation, slowing growth, and rising interest rates, Wuensch tells investors in a research note. What we don't know yet is how far the derating will go and where does medical technology shake out, balancing an elective procedure recovery with macro headwinds, says the analyst. "When is the right time to catch a falling knife? If recent history is any suggestion, the answer could be 'soon,'" writes Wuensch.

ShowHide Related Items >><<
JNJ Johnson & Johnson
$178.04 /

+1.18 (+0.67%)

JNJ Johnson & Johnson
$178.04 /

+1.18 (+0.67%)

04/29/22 Chardan
Emergent BioSolutions price target lowered to $65 from $75 at Chardan
04/20/22 Credit Suisse
Johnson & Johnson price target raised to $205 from $200 at Credit Suisse
04/20/22 Citi
Johnson & Johnson price target raised to $210 from $203 at Citi
04/19/22 Stifel
J&J notes more-positive Q1 trends, U.S. Spine 'a relative outlier,' says Stifel
JNJ Johnson & Johnson
$178.04 /

+1.18 (+0.67%)

JNJ Johnson & Johnson
$178.04 /

+1.18 (+0.67%)

JNJ Johnson & Johnson
$178.04 /

+1.18 (+0.67%)

JNJ Johnson & Johnson
$178.04 /

+1.18 (+0.67%)

Over a week ago
Hot Stocks
J&J appoints Thibaut Mongon as CEO Designate of new consumer health company » 06:34
05/11/22
05/11
06:34
05/11/22
06:34
JNJ

Johnson & Johnson

$177.13 /

-0.19 (-0.11%)

Johnson & Johnson…

Johnson & Johnson announced the appointment of Thibaut Mongon as CEO Designate and Paul Ruh as CFO Designate of the future, listed New Consumer Health Company. The company said, "As announced in November 2021, the planned separation would create two global leaders - the new Johnson & Johnson and the New Consumer Health Company - that are better positioned to deliver improved health outcomes for patients and consumers through innovation, pursue more targeted business strategies and accelerate growth.: This leadership transition will occur upon completion of the planned separation of the Consumer Health business, expected to occur within 2023, subject to legal requirements including consultation with works councils and employee representatives, as required. Directors and additional executive leadership appointments will be determined in the coming months as the planned separation process progresses. A business leader with more than 20 years of global experience at Johnson & Johnson, Thibaut Mongon has served as Executive Vice President and Worldwide Chairman of Consumer Health at Johnson & Johnson since 2019. Ruh joined Johnson & Johnson five years ago to become the CFO of the Consumer Health business

ShowHide Related Items >><<
JNJ Johnson & Johnson
$177.13 /

-0.19 (-0.11%)

JNJ Johnson & Johnson
$177.13 /

-0.19 (-0.11%)

04/29/22 Chardan
Emergent BioSolutions price target lowered to $65 from $75 at Chardan
04/20/22 Credit Suisse
Johnson & Johnson price target raised to $205 from $200 at Credit Suisse
04/20/22 Citi
Johnson & Johnson price target raised to $210 from $203 at Citi
04/19/22 Stifel
J&J notes more-positive Q1 trends, U.S. Spine 'a relative outlier,' says Stifel
JNJ Johnson & Johnson
$177.13 /

-0.19 (-0.11%)

JNJ Johnson & Johnson
$177.13 /

-0.19 (-0.11%)

JNJ Johnson & Johnson
$177.13 /

-0.19 (-0.11%)

JNJ Johnson & Johnson
$177.13 /

-0.19 (-0.11%)

Periodicals
Emergent plant's quality problems led to 400M discarded vaccines, WSJ reports » 11:25
05/10/22
05/10
11:25
05/10/22
11:25
EBS

Emergent BioSolutions

$30.41 /

-0.18 (-0.59%)

, JNJ

Johnson & Johnson

$177.42 /

+0.1 (+0.06%)

, AZN

AstraZeneca

$63.74 /

+1.16 (+1.85%)

Key ingredients that…

Key ingredients that would have amounted to roughly 400 million Johnson and Johnson (JNJ) and AstraZeneca (AZN) vaccine doses were discarded due to quality problems at Emergent BioSolutions' (EBS) Baltimore plant, The Wall Street Journal's Liz Essley Whyte reports, citing a new report from Congress. According to the report by the House Select Subcommittee on the Coronavirus Crisis and the House Committee on Oversight and Reform, the destroyed doses were much more than the 75M, and later 85M, doses that government and company officials previously said. "Emergent's failures wasted hundreds of millions of taxpayer dollars and impacted our country's ability to meet the urgent, global need for coronavirus vaccines," said the report. Reference Link

ShowHide Related Items >><<
JNJ Johnson & Johnson
$177.42 /

+0.1 (+0.06%)

EBS Emergent BioSolutions
$30.41 /

-0.18 (-0.59%)

AZN AstraZeneca
$63.74 /

+1.16 (+1.85%)

EBS Emergent BioSolutions
$30.41 /

-0.18 (-0.59%)

05/04/22 Wells Fargo
Emergent BioSolutions price target lowered to $38 from $46 at Wells Fargo
04/29/22 Cantor Fitzgerald
Emergent BioSolutions downgraded to Neutral from Overweight at Cantor Fitzgerald
04/29/22 Cowen
Emergent BioSolutions price target lowered to $30 from $40 at Cowen
04/29/22 Chardan
Emergent BioSolutions price target lowered to $65 from $75 at Chardan
JNJ Johnson & Johnson
$177.42 /

+0.1 (+0.06%)

04/20/22 Credit Suisse
Johnson & Johnson price target raised to $205 from $200 at Credit Suisse
04/20/22 Citi
Johnson & Johnson price target raised to $210 from $203 at Citi
04/19/22 Stifel
J&J notes more-positive Q1 trends, U.S. Spine 'a relative outlier,' says Stifel
AZN AstraZeneca
$63.74 /

+1.16 (+1.85%)

04/21/22 Morgan Stanley
AstraZeneca price target raised to 11,100 GBp from 10,200 GBp at Morgan Stanley
04/14/22 Barclays
AstraZeneca price target raised to 12,000 GBp from 11,500 GBp at Barclays
04/12/22 Piper Sandler
Schrodinger has 'potent and highly selective' molecule , says Piper Sandler
04/08/22 Credit Suisse
AstraZeneca price target raised to 11,000 GBp from 9,000 GBp at Credit Suisse
JNJ Johnson & Johnson
$177.42 /

+0.1 (+0.06%)

EBS Emergent BioSolutions
$30.41 /

-0.18 (-0.59%)

AZN AstraZeneca
$63.74 /

+1.16 (+1.85%)

JNJ Johnson & Johnson
$177.42 /

+0.1 (+0.06%)

AZN AstraZeneca
$63.74 /

+1.16 (+1.85%)

JNJ Johnson & Johnson
$177.42 /

+0.1 (+0.06%)

AZN AstraZeneca
$63.74 /

+1.16 (+1.85%)

JNJ Johnson & Johnson
$177.42 /

+0.1 (+0.06%)

AZN AstraZeneca
$63.74 /

+1.16 (+1.85%)

On The Fly
What You Missed On Wall Street On Friday » 16:37
05/06/22
05/06
16:37
05/06/22
16:37
SQ

Block

$96.20 /

+0.59 (+0.62%)

, ZG

Zillow Group

$37.37 /

-1.705 (-4.36%)

, Z

Zillow

$38.04 /

-1.74 (-4.37%)

, UAA

Under Armour

$10.87 /

-3.425 (-23.96%)

, UA

Under Armour

$9.84 /

-3.425 (-25.82%)

, JNJ

Johnson & Johnson

$176.45 /

-0.53 (-0.30%)

, BLCO

Bausch + Lomb

$19.98 /

+1.47 (+7.94%)

, BHC

Bausch Health

$16.07 /

-0.685 (-4.09%)

, FUBO

FuboTV

$3.25 /

-0.875 (-21.24%)

, VRTX

Vertex Pharmaceuticals

$253.65 /

-13.41 (-5.02%)

, MLCO

Melco Resorts & Entertainment

$5.03 /

-0.165 (-3.18%)

, AMRN

Amarin

$1.34 /

-0.01 (-0.74%)

, SPCE

Virgin Galactic

$6.80 /

-0.68 (-9.09%)

, PTON

Peloton

$15.71 /

-1.3 (-7.64%)

, TSLA

Tesla

$865.09 /

-8.26 (-0.95%)

, AMZN

Amazon.com

$2,294.47 /

-31.49 (-1.35%)

, RADI

Radius Global Infrastructure

$14.73 /

+2.26 (+18.12%)

, SBUX

Starbucks

$76.53 /

-0.94 (-1.21%)

, FNKO

Funko

$21.25 /

+4.545 (+27.22%)

, EBAY

eBay

$48.82 /

+0.77 (+1.60%)

, CCXI

ChemoCentryx

$17.40 /

+1.79 (+11.47%)

, VST

Vistra

$26.60 /

+1.19 (+4.68%)

, STLA

Stellantis

$13.92 /

+0.51 (+3.80%)

, GPRO

GoPro

$7.15 /

-1.605 (-18.34%)

, ENDP

Endo

$1.42 /

-0.62 (-30.47%)

, BILL

Bill.com

$120.88 /

-31.47 (-20.66%)

, DKNG

DraftKings

$13.14 /

-1.28 (-8.88%)

, CI

Cigna

$266.82 /

+14.69 (+5.83%)

, DISH

Dish

$22.23 /

-5.26 (-19.14%)

, NET

Cloudflare

$65.56 /

-12.305 (-15.80%)

, GT

Goodyear Tire

$12.31 /

-1.32 (-9.68%)

Get caught up quickly on…

ShowHide Related Items >><<
ZG Zillow Group
$37.37 /

-1.705 (-4.36%)

Z Zillow
$38.04 /

-1.74 (-4.37%)

VST Vistra
$26.60 /

+1.19 (+4.68%)

VRTX Vertex Pharmaceuticals
$253.65 /

-13.41 (-5.02%)

UAA Under Armour
$10.87 /

-3.425 (-23.96%)

UA Under Armour
$9.84 /

-3.425 (-25.82%)

TSLA Tesla
$865.09 /

-8.26 (-0.95%)

STLA Stellantis
$13.92 /

+0.51 (+3.80%)

SQ Block
$96.20 /

+0.59 (+0.62%)

SPCE Virgin Galactic
$6.80 /

-0.68 (-9.09%)

SBUX Starbucks
$76.53 /

-0.94 (-1.21%)

RADI Radius Global Infrastructure
$14.73 /

+2.26 (+18.12%)

PTON Peloton
$15.71 /

-1.3 (-7.64%)

NET Cloudflare
$65.56 /

-12.305 (-15.80%)

MLCO Melco Resorts & Entertainment
$5.03 /

-0.165 (-3.18%)

JNJ Johnson & Johnson
$176.45 /

-0.53 (-0.30%)

GT Goodyear Tire
$12.31 /

-1.32 (-9.68%)

GPRO GoPro
$7.15 /

-1.605 (-18.34%)

FUBO FuboTV
$3.25 /

-0.875 (-21.24%)

FNKO Funko
$21.25 /

+4.545 (+27.22%)

ENDP Endo
$1.42 /

-0.62 (-30.47%)

EBAY eBay
$48.82 /

+0.77 (+1.60%)

DKNG DraftKings
$13.14 /

-1.28 (-8.88%)

DISH Dish
$22.23 /

-5.26 (-19.14%)

CI Cigna
$266.82 /

+14.69 (+5.83%)

CCXI ChemoCentryx
$17.40 /

+1.79 (+11.47%)

BLCO Bausch + Lomb
$19.98 /

+1.47 (+7.94%)

BILL Bill.com
$120.88 /

-31.47 (-20.66%)

BHC Bausch Health
$16.07 /

-0.685 (-4.09%)

AMZN Amazon.com
$2,294.47 /

-31.49 (-1.35%)

AMRN Amarin
$1.34 /

-0.01 (-0.74%)

SQ Block
$96.20 /

+0.59 (+0.62%)

05/06/22 Truist
Block price target lowered to $165 from $220 at Truist
05/06/22 Cowen
Block price target lowered to $148 from $188 at Cowen
05/06/22 MoffettNathanson
Block price target lowered to $170 from $200 at MoffettNathanson
05/06/22 BTIG
Block price target lowered to $175 from $230 at BTIG
ZG Zillow Group
$37.37 /

-1.705 (-4.36%)

05/06/22 Benchmark
Zillow Group price target lowered to $65 from $115 at Benchmark
05/06/22 Truist
Zillow Group price target lowered to $41 from $58 at Truist
05/06/22 Piper Sandler
Zillow Group price target lowered to $39 from $57 at Piper Sandler
04/26/22 RBC Capital
Zillow Group price target lowered to $65 from $70 at RBC Capital
Z Zillow
$38.04 /

-1.74 (-4.37%)

03/30/22 Goldman Sachs
Zillow Group initiated with a Neutral at Goldman Sachs
03/17/22 Piper Sandler
Zillow Group price target lowered to $57 from $64 at Piper Sandler
UAA Under Armour
$10.87 /

-3.425 (-23.96%)

05/06/22 Stifel
Under Armour price target lowered to $13 from $18 at Stifel
04/26/22 OTR Global
Under Armour view downgraded to Mixed from Positive at OTR Global
04/25/22 Deutsche Bank
Skechers price target lowered to $61 from $62 at Deutsche Bank
04/01/22 Barclays
Under Armour price target lowered to $22 from $24 at Barclays
UA Under Armour
$9.84 /

-3.425 (-25.82%)

03/09/22 JPMorgan
Under Armour price target lowered to $23 from $28 at JPMorgan
JNJ Johnson & Johnson
$176.45 /

-0.53 (-0.30%)

04/29/22 Chardan
Emergent BioSolutions price target lowered to $65 from $75 at Chardan
04/20/22 Credit Suisse
Johnson & Johnson price target raised to $205 from $200 at Credit Suisse
04/20/22 Citi
Johnson & Johnson price target raised to $210 from $203 at Citi
04/19/22 Stifel
J&J notes more-positive Q1 trends, U.S. Spine 'a relative outlier,' says Stifel
BLCO Bausch + Lomb
$19.98 /

+1.47 (+7.94%)

BHC Bausch Health
$16.07 /

-0.685 (-4.09%)

02/01/22 RBC Capital
Bausch Health price target lowered to $34 from $40 at RBC Capital
11/03/21 JPMorgan
Bausch Health earnings selloff a buying opportunity, says JPMorgan
09/21/21 JPMorgan
Bausch has 50% upside based on sum-of-the-parts, says JPMorgan
08/04/21 JPMorgan
Bausch Health selloff on Solta IPO plans overdone, says JPMorgan
FUBO FuboTV
$3.25 /

-0.875 (-21.24%)

05/06/22 Needham
FuboTV price target lowered to $5 from $15 at Needham
05/06/22 Evercore ISI
FuboTV price target lowered to $7 from $20 at Evercore ISI
05/06/22 JPMorgan
FuboTV downgraded to Underweight from Neutral at JPMorgan
05/06/22 Roth Capital
FuboTV downgraded to Neutral on slowing growth at Roth Capital
VRTX Vertex Pharmaceuticals
$253.65 /

-13.41 (-5.02%)

05/06/22 Wells Fargo
Vertex Pharmaceuticals price target raised to $305 from $300 at Wells Fargo
05/06/22 Baird
Vertex Pharmaceuticals downgraded to Neutral at Baird after 21% advance
05/06/22 Baird
Vertex Pharmaceuticals downgraded to Neutral from Outperform at Baird
05/06/22 Piper Sandler
Vertex Pharmaceuticals price target lowered to $242 from $249 at Piper Sandler
MLCO Melco Resorts & Entertainment
$5.03 /

-0.165 (-3.18%)

05/06/22 CLSA
Melco Resorts & Entertainment upgraded to Buy from Outperform at CLSA
04/12/22 Citi
Citi opens '30-day positive Catalyst Watches' on Melco, Galaxy
01/18/22 Citi
Melco Resorts & Entertainment price target raised to $15 from $13.50 at Citi
01/10/22 Citi
Melco Resorts price target lowered to $13.50 from $14.50 at Citi
AMRN Amarin
$1.34 /

-0.01 (-0.74%)

05/06/22 JPMorgan
JPMorgan downgrades Amarin to sell on headwinds in U.S., Europe
05/06/22 JPMorgan
Amarin downgraded to Underweight from Neutral at JPMorgan
05/05/22 H.C. Wainwright
Amarin downgraded to Neutral from Buy at H.C. Wainwright
05/05/22 SVB Leerink
Amarin downgraded to Market Perform from Outperform at SVB Leerink
SPCE Virgin Galactic
$6.80 /

-0.68 (-9.09%)

05/06/22 Canaccord
Virgin Galactic downgraded to Hold at Canaccord after commercial launch delay
05/06/22 Canaccord
Virgin Galactic downgraded to Hold from Buy at Canaccord
02/24/22 Cowen
Virgin Galactic price target lowered to $15 from $25 at Cowen
02/24/22 Susquehanna
Virgin Galactic price target lowered to $9.00 from $22 at Susquehanna
PTON Peloton
$15.71 /

-1.3 (-7.64%)

04/19/22 Citi
Peloton assumed with Buy from Neutral at Citi
04/08/22 Morgan Stanley
Peloton may top 3M Connected Fitness subscribers in Q3, says Morgan Stanley
03/31/22 Evercore ISI
Peloton shares may stay range-bound in near-to-mid-term, says Evercore ISI
03/14/22 Bernstein
Peloton initiated with an Outperform at Bernstein
TSLA Tesla
$865.09 /

-8.26 (-0.95%)

04/27/22 Wedbush
Twitter transaction 'was never ideal' for Tesla investors, says Wedbush
04/26/22 Wedbush
'Soap opera' now ends with Musk owning Twitter, says Wedbush
04/25/22 Gordon Haskett
Twitter bid more attractive after market selloff, says Gordon Haskett
04/25/22 Wedbush
Twitter bid unlikely to result in major sale of Musk's Tesla stock, says Wedbush
AMZN Amazon.com
$2,294.47 /

-31.49 (-1.35%)

05/02/22 Piper Sandler
Piper Sandler favors Rivian for exposure to commercial vans
05/02/22 Wedbush
Amazon.com removed from Best Ideas List at Wedbush
05/02/22 KeyBanc
Shopify price target lowered to $650 from $1,000 at KeyBanc
05/02/22 Citi
Amazon overcapacity already previewed in UPS results, says Citi
RADI Radius Global Infrastructure
$14.73 /

+2.26 (+18.12%)

11/12/21
Fly Intel: Top five analyst upgrades
11/12/21 Raymond James
Raymond James upgrades Radius Global to Strong Buy on 'significant upside'
11/12/21 Raymond James
Radius Global upgraded to Strong Buy from Outperform at Raymond James
SBUX Starbucks
$76.53 /

-0.94 (-1.21%)

05/04/22 MKM Partners
Starbucks price target lowered to $98 from $105 at MKM Partners
05/04/22 Morgan Stanley
Starbucks price target lowered to $87 from $94 at Morgan Stanley
05/04/22 Cowen
Starbucks price target lowered to $94 from $115 at Cowen
05/04/22 BMO Capital
Starbucks price target lowered to $105 from $115 at BMO Capital
FNKO Funko
$21.25 /

+4.545 (+27.22%)

03/07/22 BMO Capital
Funko price target raised to $21 from $18 at BMO Capital
03/04/22 DA Davidson
Funko price target raised to $46 from $34 at DA Davidson
08/31/21
Fly Intel: Top five analyst upgrades
08/31/21 Jefferies
Jefferies upgrades Funko to Buy on confidence in 10%-plus growth
EBAY eBay
$48.82 /

+0.77 (+1.60%)

05/06/22 Wells Fargo
eBay price target lowered to $58 from $65 at Wells Fargo
05/06/22 Mizuho
eBay price target lowered to $50 from $60 at Mizuho
05/05/22 Baird
eBay price target lowered to $65 from $80 at Baird
05/05/22 Stifel
eBay price target lowered to $62 from $70 at Stifel
CCXI ChemoCentryx
$17.40 /

+1.79 (+11.47%)

03/02/22 Raymond James
ChemoCentryx could beat consensus 'handily' in Q2, says Raymond James
03/02/22 Stifel
ChemoCentryx's Q4 was positive-launch quarter, says Stifel
11/15/21 Raymond James
InflaRx's ANCA vasculitis data 'solid,' says Raymond James
11/10/21 Raymond James
ChemoCentryx price target raised to $110 from $107 at Raymond James
VST Vistra
$26.60 /

+1.19 (+4.68%)

10/13/21 BMO Capital
Vistra price target raised to $27 from $25 at BMO Capital
09/30/21 BofA
Vistra added to 'US 1 list' at BofA
09/29/21 BofA
Vistra added to US 1 List at BofA
07/22/21 Guggenheim
Guggenheim says 'time is right' to upgrade Vistra to Buy
STLA Stellantis
$13.92 /

+0.51 (+3.80%)

05/06/22 DZ Bank
Stellantis upgraded to Buy from Hold at DZ Bank
04/26/22 BofA
Stellantis downgraded to Neutral from Buy at BofA
03/23/22 RBC Capital
RBC cut 2022, 2023 auto forecast on lingering supply chain issues
03/15/22 Jefferies
Stellantis price target lowered to EUR 20 from EUR 25 at Jefferies
GPRO GoPro
$7.15 /

-1.605 (-18.34%)

05/06/22 Citi
GoPro price target lowered to $8 from $9 at Citi
03/14/22 Jefferies
Jefferies 'pleased' to see GoPro taking 'more aggressive competitive posture'
02/28/22 Jefferies
Jefferies starts GoPro at Buy after 'impressive strategic realignment'
02/28/22 Jefferies
GoPro initiated with a Buy at Jefferies
ENDP Endo
$1.42 /

-0.62 (-30.47%)

05/06/22 Piper Sandler
Piper downgrades Endo to sell, says 'going from bad to worse'
05/06/22 Piper Sandler
Endo downgraded to Underweight from Neutral at Piper Sandler
03/09/22 Citi
Endo price target lowered to $6 from $11 at Citi
03/03/22 BMO Capital
Endo price target lowered to $4 from $8 at BMO Capital
BILL Bill.com
$120.88 /

-31.47 (-20.66%)

05/06/22 Needham
Bill.com price target lowered to $200 from $370 at Needham
05/06/22 BTIG
Bill.com price target lowered to $300 from $375 at BTIG
05/06/22 Canaccord
Bill.com price target lowered to $250 from $366 at Canaccord
05/06/22 Oppenheimer
Bill.com price target lowered to $190 from $285 at Oppenheimer
DKNG DraftKings
$13.14 /

-1.28 (-8.88%)

05/04/22 Cowen
DraftKings price target lowered to $50 from $60 at Cowen
03/17/22 UBS
Genius Sports price target lowered to $5 from $9 at UBS
03/17/22 UBS
DraftKings price target lowered to $18 from $44 at UBS
03/07/22 Argus
DraftKings cut to Hold at Argus on growing Wynn and MGM competition
CI Cigna
$266.82 /

+14.69 (+5.83%)

04/07/22 Truist
Cigna price target raised to $290 from $275 at Truist
03/02/22 Mizuho
Cigna price target raised to $266 from $245 at Mizuho
02/07/22 RBC Capital
Cigna downgraded to Sector Perform from Outperform at RBC Capital
02/07/22 Barclays
Convey Health price target lowered to $12 from $16 at Barclays
DISH Dish
$22.23 /

-5.26 (-19.14%)

03/21/22 Citi
Dish price target lowered to $46 from $52 at Citi
03/08/22 UBS
Dish upgraded to Buy from Neutral at UBS
02/25/22 Truist
Dish price target lowered to $32 from $40 at Truist
02/25/22 Deutsche Bank
Dish shares have bottomed, says Deutsche Bank
NET Cloudflare
$65.56 /

-12.305 (-15.80%)

05/06/22 Truist
Cloudflare price target lowered to $140 from $180 at Truist
05/06/22 Mizuho
Cloudflare price target lowered to $90 from $135 at Mizuho
05/06/22 Citi
Cloudflare price target lowered to $95 from $120 at Citi
05/02/22 Cowen
Cloudflare price target lowered to $200 from $250 at Cowen
GT Goodyear Tire
$12.31 /

-1.32 (-9.68%)

04/21/22 Deutsche Bank
Goodyear Tire price target lowered to $19 from $30 at Deutsche Bank
04/11/22 Exane BNP Paribas
Goodyear Tire initiated with a Neutral at Exane BNP Paribas
02/22/22 Jefferies
Goodyear Tire downgraded to Hold from Buy at Jefferies
02/14/22 Nomura
Goodyear Tire upgraded to Neutral at Nomura after selloff
ZG Zillow Group
$37.37 /

-1.705 (-4.36%)

Z Zillow
$38.04 /

-1.74 (-4.37%)

VST Vistra
$26.60 /

+1.19 (+4.68%)

VRTX Vertex Pharmaceuticals
$253.65 /

-13.41 (-5.02%)

UAA Under Armour
$10.87 /

-3.425 (-23.96%)

TSLA Tesla
$865.09 /

-8.26 (-0.95%)

STLA Stellantis
$13.92 /

+0.51 (+3.80%)

SQ Block
$96.20 /

+0.59 (+0.62%)

SPCE Virgin Galactic
$6.80 /

-0.68 (-9.09%)

SBUX Starbucks
$76.53 /

-0.94 (-1.21%)

RADI Radius Global Infrastructure
$14.73 /

+2.26 (+18.12%)

PTON Peloton
$15.71 /

-1.3 (-7.64%)

NET Cloudflare
$65.56 /

-12.305 (-15.80%)

MLCO Melco Resorts & Entertainment
$5.03 /

-0.165 (-3.18%)

JNJ Johnson & Johnson
$176.45 /

-0.53 (-0.30%)

GT Goodyear Tire
$12.31 /

-1.32 (-9.68%)

GPRO GoPro
$7.15 /

-1.605 (-18.34%)

FUBO FuboTV
$3.25 /

-0.875 (-21.24%)

FNKO Funko
$21.25 /

+4.545 (+27.22%)

ENDP Endo
$1.42 /

-0.62 (-30.47%)

EBAY eBay
$48.82 /

+0.77 (+1.60%)

DKNG DraftKings
$13.14 /

-1.28 (-8.88%)

DISH Dish
$22.23 /

-5.26 (-19.14%)

CI Cigna
$266.82 /

+14.69 (+5.83%)

CCXI ChemoCentryx
$17.40 /

+1.79 (+11.47%)

BILL Bill.com
$120.88 /

-31.47 (-20.66%)

BHC Bausch Health
$16.07 /

-0.685 (-4.09%)

AMZN Amazon.com
$2,294.47 /

-31.49 (-1.35%)

AMRN Amarin
$1.34 /

-0.01 (-0.74%)

  • 06
    May
  • 16
    Nov
  • 22
    Sep
ZG Zillow Group
$37.37 /

-1.705 (-4.36%)

Z Zillow
$38.04 /

-1.74 (-4.37%)

VRTX Vertex Pharmaceuticals
$253.65 /

-13.41 (-5.02%)

UAA Under Armour
$10.87 /

-3.425 (-23.96%)

TSLA Tesla
$865.09 /

-8.26 (-0.95%)

STLA Stellantis
$13.92 /

+0.51 (+3.80%)

SQ Block
$96.20 /

+0.59 (+0.62%)

SBUX Starbucks
$76.53 /

-0.94 (-1.21%)

RADI Radius Global Infrastructure
$14.73 /

+2.26 (+18.12%)

PTON Peloton
$15.71 /

-1.3 (-7.64%)

NET Cloudflare
$65.56 /

-12.305 (-15.80%)

MLCO Melco Resorts & Entertainment
$5.03 /

-0.165 (-3.18%)

JNJ Johnson & Johnson
$176.45 /

-0.53 (-0.30%)

GT Goodyear Tire
$12.31 /

-1.32 (-9.68%)

GPRO GoPro
$7.15 /

-1.605 (-18.34%)

FUBO FuboTV
$3.25 /

-0.875 (-21.24%)

EBAY eBay
$48.82 /

+0.77 (+1.60%)

DKNG DraftKings
$13.14 /

-1.28 (-8.88%)

DISH Dish
$22.23 /

-5.26 (-19.14%)

CI Cigna
$266.82 /

+14.69 (+5.83%)

BLCO Bausch + Lomb
$19.98 /

+1.47 (+7.94%)

BHC Bausch Health
$16.07 /

-0.685 (-4.09%)

AMZN Amazon.com
$2,294.47 /

-31.49 (-1.35%)

ZG Zillow Group
$37.37 /

-1.705 (-4.36%)

Z Zillow
$38.04 /

-1.74 (-4.37%)

VRTX Vertex Pharmaceuticals
$253.65 /

-13.41 (-5.02%)

UAA Under Armour
$10.87 /

-3.425 (-23.96%)

TSLA Tesla
$865.09 /

-8.26 (-0.95%)

STLA Stellantis
$13.92 /

+0.51 (+3.80%)

SQ Block
$96.20 /

+0.59 (+0.62%)

SPCE Virgin Galactic
$6.80 /

-0.68 (-9.09%)

SBUX Starbucks
$76.53 /

-0.94 (-1.21%)

PTON Peloton
$15.71 /

-1.3 (-7.64%)

NET Cloudflare
$65.56 /

-12.305 (-15.80%)

MLCO Melco Resorts & Entertainment
$5.03 /

-0.165 (-3.18%)

JNJ Johnson & Johnson
$176.45 /

-0.53 (-0.30%)

GT Goodyear Tire
$12.31 /

-1.32 (-9.68%)

GPRO GoPro
$7.15 /

-1.605 (-18.34%)

FUBO FuboTV
$3.25 /

-0.875 (-21.24%)

FNKO Funko
$21.25 /

+4.545 (+27.22%)

ENDP Endo
$1.42 /

-0.62 (-30.47%)

EBAY eBay
$48.82 /

+0.77 (+1.60%)

DKNG DraftKings
$13.14 /

-1.28 (-8.88%)

DISH Dish
$22.23 /

-5.26 (-19.14%)

CI Cigna
$266.82 /

+14.69 (+5.83%)

CCXI ChemoCentryx
$17.40 /

+1.79 (+11.47%)

BLCO Bausch + Lomb
$19.98 /

+1.47 (+7.94%)

BILL Bill.com
$120.88 /

-31.47 (-20.66%)

BHC Bausch Health
$16.07 /

-0.685 (-4.09%)

AMZN Amazon.com
$2,294.47 /

-31.49 (-1.35%)

AMRN Amarin
$1.34 /

-0.01 (-0.74%)

ZG Zillow Group
$37.37 /

-1.705 (-4.36%)

Z Zillow
$38.04 /

-1.74 (-4.37%)

VST Vistra
$26.60 /

+1.19 (+4.68%)

VRTX Vertex Pharmaceuticals
$253.65 /

-13.41 (-5.02%)

UAA Under Armour
$10.87 /

-3.425 (-23.96%)

UA Under Armour
$9.84 /

-3.425 (-25.82%)

TSLA Tesla
$865.09 /

-8.26 (-0.95%)

STLA Stellantis
$13.92 /

+0.51 (+3.80%)

SQ Block
$96.20 /

+0.59 (+0.62%)

SPCE Virgin Galactic
$6.80 /

-0.68 (-9.09%)

SBUX Starbucks
$76.53 /

-0.94 (-1.21%)

PTON Peloton
$15.71 /

-1.3 (-7.64%)

NET Cloudflare
$65.56 /

-12.305 (-15.80%)

MLCO Melco Resorts & Entertainment
$5.03 /

-0.165 (-3.18%)

JNJ Johnson & Johnson
$176.45 /

-0.53 (-0.30%)

GT Goodyear Tire
$12.31 /

-1.32 (-9.68%)

GPRO GoPro
$7.15 /

-1.605 (-18.34%)

FUBO FuboTV
$3.25 /

-0.875 (-21.24%)

EBAY eBay
$48.82 /

+0.77 (+1.60%)

DKNG DraftKings
$13.14 /

-1.28 (-8.88%)

DISH Dish
$22.23 /

-5.26 (-19.14%)

CI Cigna
$266.82 /

+14.69 (+5.83%)

BILL Bill.com
$120.88 /

-31.47 (-20.66%)

BHC Bausch Health
$16.07 /

-0.685 (-4.09%)

AMZN Amazon.com
$2,294.47 /

-31.49 (-1.35%)

AMRN Amarin
$1.34 /

-0.01 (-0.74%)

On The Fly
What You Missed On Wall Street This Morning » 12:11
05/06/22
05/06
12:11
05/06/22
12:11
SQ

Block

$96.89 /

+1.28 (+1.34%)

, JNJ

Johnson & Johnson

$174.93 /

-2.05 (-1.16%)

, ZG

Zillow Group

$37.80 /

-1.275 (-3.26%)

, Z

Zillow

$38.84 /

-0.94 (-2.36%)

, UA

Under Armour

$10.02 /

-3.245 (-24.46%)

, UAA

Under Armour

$11.26 /

-3.035 (-21.23%)

, DKNG

DraftKings

$13.85 /

-0.575 (-3.99%)

, PTON

Peloton

$15.73 /

-1.28 (-7.52%)

, TSLA

Tesla

$872.18 /

-1.17 (-0.13%)

, AMZN

Amazon.com

$2,324.78 /

-1.18 (-0.05%)

, SONY

Sony

$84.05 /

-0.81 (-0.95%)

, STLA

Stellantis

$13.93 /

+0.52 (+3.88%)

, CI

Cigna

$262.98 /

+10.85 (+4.30%)

, DISH

Dish

$24.00 /

-3.485 (-12.68%)

, NET

Cloudflare

$67.14 /

-10.72 (-13.77%)

, IEP

Icahn Enterprises

$53.68 /

+0.47 (+0.88%)

, GT

Goodyear Tire

$12.60 /

-1.03 (-7.56%)

, F

Ford

$14.23 /

-0.315 (-2.17%)

, FNKO

Funko

$20.25 /

+3.55 (+21.26%)

, EBAY

eBay

$48.89 /

+0.845 (+1.76%)

, CCXI

ChemoCentryx

$17.86 /

+2.25 (+14.41%)

, VST

Vistra

$26.62 /

+1.21 (+4.76%)

, GPRO

GoPro

$7.12 /

-1.635 (-18.69%)

, ENDP

Endo

$1.39 /

-0.65 (-31.94%)

, BILL

Bill.com

$127.70 /

-24.65 (-16.18%)

, FUBO

FuboTV

$3.36 /

-0.76 (-18.45%)

, VRTX

Vertex Pharmaceuticals

$254.63 /

-12.43 (-4.65%)

, MLCO

Melco Resorts & Entertainment

$5.20 /

+0.005 (+0.10%)

, AMRN

Amarin

$1.32 /

-0.025 (-1.86%)

, SPCE

Virgin Galactic

$6.87 /

-0.615 (-8.22%)

Get caught up quickly on…

ShowHide Related Items >><<
ZG Zillow Group
$37.80 /

-1.275 (-3.26%)

Z Zillow
$38.84 /

-0.94 (-2.36%)

VST Vistra
$26.62 /

+1.21 (+4.76%)

VRTX Vertex Pharmaceuticals
$254.63 /

-12.43 (-4.65%)

UAA Under Armour
$11.26 /

-3.035 (-21.23%)

UA Under Armour
$10.02 /

-3.245 (-24.46%)

TSLA Tesla
$872.18 /

-1.17 (-0.13%)

STLA Stellantis
$13.93 /

+0.52 (+3.88%)

SQ Block
$96.89 /

+1.28 (+1.34%)

SPCE Virgin Galactic
$6.87 /

-0.615 (-8.22%)

SONY Sony
$84.05 /

-0.81 (-0.95%)

PTON Peloton
$15.73 /

-1.28 (-7.52%)

NET Cloudflare
$67.14 /

-10.72 (-13.77%)

MLCO Melco Resorts & Entertainment
$5.20 /

+0.005 (+0.10%)

JNJ Johnson & Johnson
$174.93 /

-2.05 (-1.16%)

IEP Icahn Enterprises
$53.68 /

+0.47 (+0.88%)

GT Goodyear Tire
$12.60 /

-1.03 (-7.56%)

GPRO GoPro
$7.12 /

-1.635 (-18.69%)

FUBO FuboTV
$3.36 /

-0.76 (-18.45%)

FNKO Funko
$20.25 /

+3.55 (+21.26%)

F Ford
$14.23 /

-0.315 (-2.17%)

ENDP Endo
$1.39 /

-0.65 (-31.94%)

EBAY eBay
$48.89 /

+0.845 (+1.76%)

DKNG DraftKings
$13.85 /

-0.575 (-3.99%)

DISH Dish
$24.00 /

-3.485 (-12.68%)

CI Cigna
$262.98 /

+10.85 (+4.30%)

CCXI ChemoCentryx
$17.86 /

+2.25 (+14.41%)

BILL Bill.com
$127.70 /

-24.65 (-16.18%)

AMZN Amazon.com
$2,324.78 /

-1.18 (-0.05%)

AMRN Amarin
$1.32 /

-0.025 (-1.86%)

SQ Block
$96.89 /

+1.28 (+1.34%)

05/06/22 Truist
Block price target lowered to $165 from $220 at Truist
05/06/22 Cowen
Block price target lowered to $148 from $188 at Cowen
05/06/22 MoffettNathanson
Block price target lowered to $170 from $200 at MoffettNathanson
05/06/22 BTIG
Block price target lowered to $175 from $230 at BTIG
JNJ Johnson & Johnson
$174.93 /

-2.05 (-1.16%)

04/29/22 Chardan
Emergent BioSolutions price target lowered to $65 from $75 at Chardan
04/20/22 Credit Suisse
Johnson & Johnson price target raised to $205 from $200 at Credit Suisse
04/20/22 Citi
Johnson & Johnson price target raised to $210 from $203 at Citi
04/19/22 Stifel
J&J notes more-positive Q1 trends, U.S. Spine 'a relative outlier,' says Stifel
ZG Zillow Group
$37.80 /

-1.275 (-3.26%)

05/06/22 Benchmark
Zillow Group price target lowered to $65 from $115 at Benchmark
05/06/22 Truist
Zillow Group price target lowered to $41 from $58 at Truist
05/06/22 Piper Sandler
Zillow Group price target lowered to $39 from $57 at Piper Sandler
04/26/22 RBC Capital
Zillow Group price target lowered to $65 from $70 at RBC Capital
Z Zillow
$38.84 /

-0.94 (-2.36%)

03/30/22 Goldman Sachs
Zillow Group initiated with a Neutral at Goldman Sachs
03/17/22 Piper Sandler
Zillow Group price target lowered to $57 from $64 at Piper Sandler
UA Under Armour
$10.02 /

-3.245 (-24.46%)

04/26/22 OTR Global
Under Armour view downgraded to Mixed from Positive at OTR Global
04/01/22 Barclays
Under Armour price target lowered to $22 from $24 at Barclays
03/09/22 JPMorgan
Under Armour price target lowered to $23 from $28 at JPMorgan
03/01/22 Cowen
Cowen likes Under Armour stepping up buybacks, trims target to $27
UAA Under Armour
$11.26 /

-3.035 (-21.23%)

04/25/22 Deutsche Bank
Skechers price target lowered to $61 from $62 at Deutsche Bank
DKNG DraftKings
$13.85 /

-0.575 (-3.99%)

05/04/22 Cowen
DraftKings price target lowered to $50 from $60 at Cowen
03/17/22 UBS
Genius Sports price target lowered to $5 from $9 at UBS
03/17/22 UBS
DraftKings price target lowered to $18 from $44 at UBS
03/07/22 Argus
DraftKings cut to Hold at Argus on growing Wynn and MGM competition
PTON Peloton
$15.73 /

-1.28 (-7.52%)

04/19/22 Citi
Peloton assumed with Buy from Neutral at Citi
04/08/22 Morgan Stanley
Peloton may top 3M Connected Fitness subscribers in Q3, says Morgan Stanley
03/31/22 Evercore ISI
Peloton shares may stay range-bound in near-to-mid-term, says Evercore ISI
03/14/22 Bernstein
Peloton initiated with an Outperform at Bernstein
TSLA Tesla
$872.18 /

-1.17 (-0.13%)

04/27/22 Wedbush
Twitter transaction 'was never ideal' for Tesla investors, says Wedbush
04/26/22 Wedbush
'Soap opera' now ends with Musk owning Twitter, says Wedbush
04/25/22 Gordon Haskett
Twitter bid more attractive after market selloff, says Gordon Haskett
04/25/22 Wedbush
Twitter bid unlikely to result in major sale of Musk's Tesla stock, says Wedbush
AMZN Amazon.com
$2,324.78 /

-1.18 (-0.05%)

05/02/22 Piper Sandler
Piper Sandler favors Rivian for exposure to commercial vans
05/02/22 Wedbush
Amazon.com removed from Best Ideas List at Wedbush
05/02/22 KeyBanc
Shopify price target lowered to $650 from $1,000 at KeyBanc
05/02/22 Citi
Amazon overcapacity already previewed in UPS results, says Citi
SONY Sony
$84.05 /

-0.81 (-0.95%)

04/13/22 CLSA
Sony downgraded to Outperform from Buy at CLSA
03/08/22 Benchmark
Take-Two next-gen 'GTA' ports to have lower price point, says Benchmark
02/07/22 Morgan Stanley
Morgan Stanley upgrades TSMC to Overweight, looking beyond current correction
01/31/22 Benchmark
Sony/Bungie deal opens path for Microsoft/Activision close, says Benchmark
STLA Stellantis
$13.93 /

+0.52 (+3.88%)

05/06/22 DZ Bank
Stellantis upgraded to Buy from Hold at DZ Bank
04/26/22 BofA
Stellantis downgraded to Neutral from Buy at BofA
03/23/22 RBC Capital
RBC cut 2022, 2023 auto forecast on lingering supply chain issues
03/15/22 Jefferies
Stellantis price target lowered to EUR 20 from EUR 25 at Jefferies
CI Cigna
$262.98 /

+10.85 (+4.30%)

04/07/22 Truist
Cigna price target raised to $290 from $275 at Truist
03/02/22 Mizuho
Cigna price target raised to $266 from $245 at Mizuho
02/07/22 RBC Capital
Cigna downgraded to Sector Perform from Outperform at RBC Capital
02/07/22 Barclays
Convey Health price target lowered to $12 from $16 at Barclays
DISH Dish
$24.00 /

-3.485 (-12.68%)

03/21/22 Citi
Dish price target lowered to $46 from $52 at Citi
03/08/22 UBS
Dish upgraded to Buy from Neutral at UBS
02/25/22 Truist
Dish price target lowered to $32 from $40 at Truist
02/25/22 Deutsche Bank
Dish shares have bottomed, says Deutsche Bank
NET Cloudflare
$67.14 /

-10.72 (-13.77%)

05/06/22 Truist
Cloudflare price target lowered to $140 from $180 at Truist
05/06/22 Mizuho
Cloudflare price target lowered to $90 from $135 at Mizuho
05/06/22 Citi
Cloudflare price target lowered to $95 from $120 at Citi
05/02/22 Cowen
Cloudflare price target lowered to $200 from $250 at Cowen
IEP Icahn Enterprises
$53.68 /

+0.47 (+0.88%)

GT Goodyear Tire
$12.60 /

-1.03 (-7.56%)

04/21/22 Deutsche Bank
Goodyear Tire price target lowered to $19 from $30 at Deutsche Bank
04/11/22 Exane BNP Paribas
Goodyear Tire initiated with a Neutral at Exane BNP Paribas
02/22/22 Jefferies
Goodyear Tire downgraded to Hold from Buy at Jefferies
02/14/22 Nomura
Goodyear Tire upgraded to Neutral at Nomura after selloff
F Ford
$14.23 /

-0.315 (-2.17%)

05/02/22 Benchmark
Ford price target lowered to $25 from $29 at Benchmark
04/28/22 Barclays
Ford Q1 may bring 'relief rally' in shares, says Barclays
04/25/22 JPMorgan
Ford price target lowered to $21 from $22 at JPMorgan
04/21/22 Deutsche Bank
Ford price target lowered to $17 from $21 at Deutsche Bank
FNKO Funko
$20.25 /

+3.55 (+21.26%)

03/07/22 BMO Capital
Funko price target raised to $21 from $18 at BMO Capital
03/04/22 DA Davidson
Funko price target raised to $46 from $34 at DA Davidson
08/31/21
Fly Intel: Top five analyst upgrades
08/31/21 Jefferies
Jefferies upgrades Funko to Buy on confidence in 10%-plus growth
EBAY eBay
$48.89 /

+0.845 (+1.76%)

05/06/22 Wells Fargo
eBay price target lowered to $58 from $65 at Wells Fargo
05/06/22 Mizuho
eBay price target lowered to $50 from $60 at Mizuho
05/05/22 Baird
eBay price target lowered to $65 from $80 at Baird
05/05/22 Stifel
eBay price target lowered to $62 from $70 at Stifel
CCXI ChemoCentryx
$17.86 /

+2.25 (+14.41%)

03/02/22 Raymond James
ChemoCentryx could beat consensus 'handily' in Q2, says Raymond James
03/02/22 Stifel
ChemoCentryx's Q4 was positive-launch quarter, says Stifel
11/15/21 Raymond James
InflaRx's ANCA vasculitis data 'solid,' says Raymond James
11/10/21 Raymond James
ChemoCentryx price target raised to $110 from $107 at Raymond James
VST Vistra
$26.62 /

+1.21 (+4.76%)

10/13/21 BMO Capital
Vistra price target raised to $27 from $25 at BMO Capital
09/30/21 BofA
Vistra added to 'US 1 list' at BofA
09/29/21 BofA
Vistra added to US 1 List at BofA
07/22/21 Guggenheim
Guggenheim says 'time is right' to upgrade Vistra to Buy
GPRO GoPro
$7.12 /

-1.635 (-18.69%)

05/06/22 Citi
GoPro price target lowered to $8 from $9 at Citi
03/14/22 Jefferies
Jefferies 'pleased' to see GoPro taking 'more aggressive competitive posture'
02/28/22 Jefferies
Jefferies starts GoPro at Buy after 'impressive strategic realignment'
02/28/22 Jefferies
GoPro initiated with a Buy at Jefferies
ENDP Endo
$1.39 /

-0.65 (-31.94%)

03/09/22 Citi
Endo price target lowered to $6 from $11 at Citi
03/03/22 BMO Capital
Endo price target lowered to $4 from $8 at BMO Capital
03/02/22 Barclays
Barclays downgrades Endo to Underweight on 'difficult path'
03/02/22 Barclays
Endo downgraded to Underweight from Equal Weight at Barclays
BILL Bill.com
$127.70 /

-24.65 (-16.18%)

05/06/22 Needham
Bill.com price target lowered to $200 from $370 at Needham
05/06/22 BTIG
Bill.com price target lowered to $300 from $375 at BTIG
05/06/22 Canaccord
Bill.com price target lowered to $250 from $366 at Canaccord
05/06/22 Oppenheimer
Bill.com price target lowered to $190 from $285 at Oppenheimer
FUBO FuboTV
$3.36 /

-0.76 (-18.45%)

05/06/22 Needham
FuboTV price target lowered to $5 from $15 at Needham
05/06/22 Evercore ISI
FuboTV price target lowered to $7 from $20 at Evercore ISI
05/06/22 JPMorgan
FuboTV downgraded to Underweight from Neutral at JPMorgan
05/06/22 Roth Capital
FuboTV downgraded to Neutral on slowing growth at Roth Capital
VRTX Vertex Pharmaceuticals
$254.63 /

-12.43 (-4.65%)

05/06/22 Wells Fargo
Vertex Pharmaceuticals price target raised to $305 from $300 at Wells Fargo
05/06/22 Baird
Vertex Pharmaceuticals downgraded to Neutral at Baird after 21% advance
05/06/22 Baird
Vertex Pharmaceuticals downgraded to Neutral from Outperform at Baird
05/06/22 Piper Sandler
Vertex Pharmaceuticals price target lowered to $242 from $249 at Piper Sandler
MLCO Melco Resorts & Entertainment
$5.20 /

+0.005 (+0.10%)

05/06/22 CLSA
Melco Resorts & Entertainment upgraded to Buy from Outperform at CLSA
04/12/22 Citi
Citi opens '30-day positive Catalyst Watches' on Melco, Galaxy
01/18/22 Citi
Melco Resorts & Entertainment price target raised to $15 from $13.50 at Citi
01/10/22 Citi
Melco Resorts price target lowered to $13.50 from $14.50 at Citi
AMRN Amarin
$1.32 /

-0.025 (-1.86%)

05/06/22 JPMorgan
JPMorgan downgrades Amarin to sell on headwinds in U.S., Europe
05/06/22 JPMorgan
Amarin downgraded to Underweight from Neutral at JPMorgan
05/05/22 H.C. Wainwright
Amarin downgraded to Neutral from Buy at H.C. Wainwright
05/05/22 SVB Leerink
Amarin downgraded to Market Perform from Outperform at SVB Leerink
SPCE Virgin Galactic
$6.87 /

-0.615 (-8.22%)

05/06/22 Canaccord
Virgin Galactic downgraded to Hold at Canaccord after commercial launch delay
05/06/22 Canaccord
Virgin Galactic downgraded to Hold from Buy at Canaccord
02/24/22 Cowen
Virgin Galactic price target lowered to $15 from $25 at Cowen
02/24/22 Susquehanna
Virgin Galactic price target lowered to $9.00 from $22 at Susquehanna
ZG Zillow Group
$37.80 /

-1.275 (-3.26%)

Z Zillow
$38.84 /

-0.94 (-2.36%)

VST Vistra
$26.62 /

+1.21 (+4.76%)

VRTX Vertex Pharmaceuticals
$254.63 /

-12.43 (-4.65%)

UA Under Armour
$10.02 /

-3.245 (-24.46%)

TSLA Tesla
$872.18 /

-1.17 (-0.13%)

STLA Stellantis
$13.93 /

+0.52 (+3.88%)

SQ Block
$96.89 /

+1.28 (+1.34%)

SPCE Virgin Galactic
$6.87 /

-0.615 (-8.22%)

PTON Peloton
$15.73 /

-1.28 (-7.52%)

NET Cloudflare
$67.14 /

-10.72 (-13.77%)

MLCO Melco Resorts & Entertainment
$5.20 /

+0.005 (+0.10%)

JNJ Johnson & Johnson
$174.93 /

-2.05 (-1.16%)

IEP Icahn Enterprises
$53.68 /

+0.47 (+0.88%)

GT Goodyear Tire
$12.60 /

-1.03 (-7.56%)

GPRO GoPro
$7.12 /

-1.635 (-18.69%)

FUBO FuboTV
$3.36 /

-0.76 (-18.45%)

FNKO Funko
$20.25 /

+3.55 (+21.26%)

F Ford
$14.23 /

-0.315 (-2.17%)

ENDP Endo
$1.39 /

-0.65 (-31.94%)

EBAY eBay
$48.89 /

+0.845 (+1.76%)

DKNG DraftKings
$13.85 /

-0.575 (-3.99%)

DISH Dish
$24.00 /

-3.485 (-12.68%)

CI Cigna
$262.98 /

+10.85 (+4.30%)

CCXI ChemoCentryx
$17.86 /

+2.25 (+14.41%)

BILL Bill.com
$127.70 /

-24.65 (-16.18%)

AMZN Amazon.com
$2,324.78 /

-1.18 (-0.05%)

AMRN Amarin
$1.32 /

-0.025 (-1.86%)

  • 16
    Nov
  • 22
    Sep
ZG Zillow Group
$37.80 /

-1.275 (-3.26%)

Z Zillow
$38.84 /

-0.94 (-2.36%)

VRTX Vertex Pharmaceuticals
$254.63 /

-12.43 (-4.65%)

UA Under Armour
$10.02 /

-3.245 (-24.46%)

TSLA Tesla
$872.18 /

-1.17 (-0.13%)

STLA Stellantis
$13.93 /

+0.52 (+3.88%)

SQ Block
$96.89 /

+1.28 (+1.34%)

SONY Sony
$84.05 /

-0.81 (-0.95%)

PTON Peloton
$15.73 /

-1.28 (-7.52%)

NET Cloudflare
$67.14 /

-10.72 (-13.77%)

MLCO Melco Resorts & Entertainment
$5.20 /

+0.005 (+0.10%)

JNJ Johnson & Johnson
$174.93 /

-2.05 (-1.16%)

GT Goodyear Tire
$12.60 /

-1.03 (-7.56%)

GPRO GoPro
$7.12 /

-1.635 (-18.69%)

FUBO FuboTV
$3.36 /

-0.76 (-18.45%)

F Ford
$14.23 /

-0.315 (-2.17%)

EBAY eBay
$48.89 /

+0.845 (+1.76%)

DKNG DraftKings
$13.85 /

-0.575 (-3.99%)

DISH Dish
$24.00 /

-3.485 (-12.68%)

CI Cigna
$262.98 /

+10.85 (+4.30%)

AMZN Amazon.com
$2,324.78 /

-1.18 (-0.05%)

ZG Zillow Group
$37.80 /

-1.275 (-3.26%)

Z Zillow
$38.84 /

-0.94 (-2.36%)

VRTX Vertex Pharmaceuticals
$254.63 /

-12.43 (-4.65%)

UA Under Armour
$10.02 /

-3.245 (-24.46%)

TSLA Tesla
$872.18 /

-1.17 (-0.13%)

STLA Stellantis
$13.93 /

+0.52 (+3.88%)

SQ Block
$96.89 /

+1.28 (+1.34%)

SPCE Virgin Galactic
$6.87 /

-0.615 (-8.22%)

SONY Sony
$84.05 /

-0.81 (-0.95%)

PTON Peloton
$15.73 /

-1.28 (-7.52%)

NET Cloudflare
$67.14 /

-10.72 (-13.77%)

MLCO Melco Resorts & Entertainment
$5.20 /

+0.005 (+0.10%)

JNJ Johnson & Johnson
$174.93 /

-2.05 (-1.16%)

GT Goodyear Tire
$12.60 /

-1.03 (-7.56%)

GPRO GoPro
$7.12 /

-1.635 (-18.69%)

FUBO FuboTV
$3.36 /

-0.76 (-18.45%)

FNKO Funko
$20.25 /

+3.55 (+21.26%)

F Ford
$14.23 /

-0.315 (-2.17%)

ENDP Endo
$1.39 /

-0.65 (-31.94%)

EBAY eBay
$48.89 /

+0.845 (+1.76%)

DKNG DraftKings
$13.85 /

-0.575 (-3.99%)

DISH Dish
$24.00 /

-3.485 (-12.68%)

CI Cigna
$262.98 /

+10.85 (+4.30%)

CCXI ChemoCentryx
$17.86 /

+2.25 (+14.41%)

BILL Bill.com
$127.70 /

-24.65 (-16.18%)

AMZN Amazon.com
$2,324.78 /

-1.18 (-0.05%)

AMRN Amarin
$1.32 /

-0.025 (-1.86%)

ZG Zillow Group
$37.80 /

-1.275 (-3.26%)

Z Zillow
$38.84 /

-0.94 (-2.36%)

VST Vistra
$26.62 /

+1.21 (+4.76%)

VRTX Vertex Pharmaceuticals
$254.63 /

-12.43 (-4.65%)

UAA Under Armour
$11.26 /

-3.035 (-21.23%)

UA Under Armour
$10.02 /

-3.245 (-24.46%)

TSLA Tesla
$872.18 /

-1.17 (-0.13%)

STLA Stellantis
$13.93 /

+0.52 (+3.88%)

SQ Block
$96.89 /

+1.28 (+1.34%)

SPCE Virgin Galactic
$6.87 /

-0.615 (-8.22%)

PTON Peloton
$15.73 /

-1.28 (-7.52%)

NET Cloudflare
$67.14 /

-10.72 (-13.77%)

MLCO Melco Resorts & Entertainment
$5.20 /

+0.005 (+0.10%)

JNJ Johnson & Johnson
$174.93 /

-2.05 (-1.16%)

GT Goodyear Tire
$12.60 /

-1.03 (-7.56%)

GPRO GoPro
$7.12 /

-1.635 (-18.69%)

FUBO FuboTV
$3.36 /

-0.76 (-18.45%)

F Ford
$14.23 /

-0.315 (-2.17%)

EBAY eBay
$48.89 /

+0.845 (+1.76%)

DKNG DraftKings
$13.85 /

-0.575 (-3.99%)

DISH Dish
$24.00 /

-3.485 (-12.68%)

CI Cigna
$262.98 /

+10.85 (+4.30%)

BILL Bill.com
$127.70 /

-24.65 (-16.18%)

AMZN Amazon.com
$2,324.78 /

-1.18 (-0.05%)

AMRN Amarin
$1.32 /

-0.025 (-1.86%)

Hot Stocks
FDA limits authorized use of J&J's COVID vaccine » 18:53
05/05/22
05/05
18:53
05/05/22
18:53
JNJ

Johnson & Johnson

$176.98 /

-3.14 (-1.74%)

The U.S. Food and Drug…

The U.S. Food and Drug Administration has limited the authorized use of the Janssen COVID-19 Vaccine to individuals 18 years of age and older for whom other authorized or approved COVID-19 vaccines are not accessible or clinically appropriate, and to individuals 18 years of age and older who elect to receive the Janssen COVID-19 Vaccine because they would otherwise not receive a COVID-19 vaccine. "We recognize that the Janssen COVID-19 Vaccine still has a role in the current pandemic response in the United States and across the global community. Our action reflects our updated analysis of the risk of TTS following administration of this vaccine and limits the use of the vaccine to certain individuals," said Peter Marks, M.D., Ph.D., director of the FDA's Center for Biologics Evaluation and Research. "Today's action demonstrates the robustness of our safety surveillance systems and our commitment to ensuring that science and data guide our decisions. We've been closely monitoring the Janssen COVID-19 Vaccine and occurrence of TTS following its administration and have used updated information from our safety surveillance systems to revise the EUA. The agency will continue to monitor the safety of the Janssen COVID-19 Vaccine and all other vaccines, and as has been the case throughout the pandemic, will thoroughly evaluate new safety information." Janssen is owned by Johnson & Johnson. Reference Link

ShowHide Related Items >><<
JNJ Johnson & Johnson
$176.98 /

-3.14 (-1.74%)

JNJ Johnson & Johnson
$176.98 /

-3.14 (-1.74%)

04/29/22 Chardan
Emergent BioSolutions price target lowered to $65 from $75 at Chardan
04/20/22 Credit Suisse
Johnson & Johnson price target raised to $205 from $200 at Credit Suisse
04/20/22 Citi
Johnson & Johnson price target raised to $210 from $203 at Citi
04/19/22 Stifel
J&J notes more-positive Q1 trends, U.S. Spine 'a relative outlier,' says Stifel
JNJ Johnson & Johnson
$176.98 /

-3.14 (-1.74%)

JNJ Johnson & Johnson
$176.98 /

-3.14 (-1.74%)

JNJ Johnson & Johnson
$176.98 /

-3.14 (-1.74%)

JNJ Johnson & Johnson
$176.98 /

-3.14 (-1.74%)

Periodicals
J&J sues SaveOnSP over use of drug cost assistance program, WSJ reports » 06:06
05/05/22
05/05
06:06
05/05/22
06:06
JNJ

Johnson & Johnson

$180.10 /

+1.82 (+1.02%)

Johnson & Johnson…

Johnson & Johnson filed a lawsuit on Wednesday accusing SaveOnSP, a drug benefit middleman firm, of contract interference and deceptive trade practices, The Wall Street Journal's Peter Loftus reports. In the lawsuit, J&J said it has paid at least $100M more in copay assistance than it otherwise would have as a result of the services provided by the firm. J&J is seeking damages and a court order that SaveOnSP stop its program. Reference Link

ShowHide Related Items >><<
JNJ Johnson & Johnson
$180.10 /

+1.82 (+1.02%)

JNJ Johnson & Johnson
$180.10 /

+1.82 (+1.02%)

04/29/22 Chardan
Emergent BioSolutions price target lowered to $65 from $75 at Chardan
04/20/22 Credit Suisse
Johnson & Johnson price target raised to $205 from $200 at Credit Suisse
04/20/22 Citi
Johnson & Johnson price target raised to $210 from $203 at Citi
04/19/22 Stifel
J&J notes more-positive Q1 trends, U.S. Spine 'a relative outlier,' says Stifel
JNJ Johnson & Johnson
$180.10 /

+1.82 (+1.02%)

JNJ Johnson & Johnson
$180.10 /

+1.82 (+1.02%)

JNJ Johnson & Johnson
$180.10 /

+1.82 (+1.02%)

JNJ Johnson & Johnson
$180.10 /

+1.82 (+1.02%)

Conference/Events
Association for Research in Vision & Ophthalmology to hold annual meeting » 04:55
05/04/22
05/04
04:55
05/04/22
04:55
ABBV

AbbVie

$149.61 /

+1.74 (+1.18%)

, ABEO

Abeona Therapeutics

/

+

, ADVM

Adverum Biotechnologies

$1.15 /

+0.03 (+2.69%)

, AERI

Aerie Pharmaceuticals

$7.96 /

+0.47 (+6.28%)

, AGN

Bought by ABBV

$193.08 /

+ (+0.00%)

, AGTC

Applied Genetic

/

+

, BAYRY

Bayer

$16.04 /

+0.23 (+1.45%)

, BMRN

BioMarin

$83.49 /

+0.18 (+0.22%)

, CE

Celanese

$150.37 /

+4.53 (+3.11%)

, CELU

Celularity

$11.38 /

-0.28 (-2.40%)

, DNA

Ginkgo Bioworks

$3.23 /

+0.105 (+3.36%)

, EDIT

Editas Medicine

$14.18 /

-0.1 (-0.70%)

, HZNP

Horizon Therapeutics

$94.70 /

-3.375 (-3.44%)

, JNJ

Johnson & Johnson

$178.28 /

-0.37 (-0.21%)

, KALA

Kala Pharmaceuticals

/

+

, KOD

Kodiak Sciences

$6.39 /

-0.065 (-1.01%)

, LCTX

Lineage Cell Therapeutics

$1.27 /

+0.065 (+5.39%)

, PRQR

ProQR Therapeutics

/

+

, REGN

Regeneron

$660.09 /

+7.73 (+1.18%)

, RGNX

Regenxbio

$28.25 /

-0.15 (-0.53%)

, RHHBY

Roche

$45.13 /

-0.37 (-0.81%)

, STOK

Stoke Therapeutics

$14.77 /

-0.21 (-1.40%)

, UBX

Unity Biotechnology

/

+

ARVO 2022 to be held in…

ARVO 2022 to be held in Denver, CO on May 1-4.

ShowHide Related Items >><<
UBX Unity Biotechnology
/

+

STOK Stoke Therapeutics
$14.77 /

-0.21 (-1.40%)

RHHBY Roche
$45.13 /

-0.37 (-0.81%)

RGNX Regenxbio
$28.25 /

-0.15 (-0.53%)

REGN Regeneron
$660.09 /

+7.73 (+1.18%)

PRQR ProQR Therapeutics
/

+

LCTX Lineage Cell Therapeutics
$1.27 /

+0.065 (+5.39%)

KOD Kodiak Sciences
$6.39 /

-0.065 (-1.01%)

KALA Kala Pharmaceuticals
/

+

JNJ Johnson & Johnson
$178.28 /

-0.37 (-0.21%)

HZNP Horizon Therapeutics
$94.70 /

-3.375 (-3.44%)

EDIT Editas Medicine
$14.18 /

-0.1 (-0.70%)

DNA Ginkgo Bioworks
$3.23 /

+0.105 (+3.36%)

CELU Celularity
$11.38 /

-0.28 (-2.40%)

CE Celanese
$150.37 /

+4.53 (+3.11%)

BMRN BioMarin
$83.49 /

+0.18 (+0.22%)

BAYRY Bayer
$16.04 /

+0.23 (+1.45%)

AGTC Applied Genetic
/

+

AERI Aerie Pharmaceuticals
$7.96 /

+0.47 (+6.28%)

ADVM Adverum Biotechnologies
$1.15 /

+0.03 (+2.69%)

ABEO Abeona Therapeutics
/

+

ABBV AbbVie
$149.61 /

+1.74 (+1.18%)

ABBV AbbVie
$149.61 /

+1.74 (+1.18%)

05/03/22 Morgan Stanley
Vertex upgraded to Equal Weight at Morgan Stanley following AbbVie failure
05/02/22 Morgan Stanley
AbbVie's recent weakness a buying opportunity, says Morgan Stanley
05/02/22 Wells Fargo
AbbVie price target raised to $200 from $165 at Wells Fargo
05/02/22 Cowen
Genmab initiated with a Market Perform at Cowen
ABEO Abeona Therapeutics
/

+

11/30/21 SVB Leerink
Abeona Therapeutics downgraded to Market Perform from Outperform at SVB Leerink
11/29/21 H.C. Wainwright
Abeona Therapeutics price target lowered to $4 from $5 at H.C. Wainwright
07/19/21 H.C. Wainwright
Abeona Therapeutics price target lowered to $5 from $8 at H.C. Wainwright
ADVM Adverum Biotechnologies
$1.15 /

+0.03 (+2.69%)

03/29/22 Chardan
Adverum Biotechnologies transferred with Neutral at Chardan
07/23/21
Fly Intel: Top five analyst downgrades
07/23/21 Goldman Sachs
Adverum Biotechnologies downgraded to Neutral from Buy at Goldman Sachs
07/23/21 SVB Leerink
Adverum Biotechnologies price target lowered to $2 from $5
AERI Aerie Pharmaceuticals
$7.96 /

+0.47 (+6.28%)

02/28/22 Citi
Aerie Pharmaceuticals price target lowered to $13 from $23 at Citi
02/25/22 Cowen
Aerie Pharmaceuticals price target lowered to $25 from $30 at Cowen
AGN Bought by ABBV
$193.08 /

+ (+0.00%)

AGTC Applied Genetic
/

+

03/29/22 Chardan
Applied Genetic transferred with Buy rating at Chardan
02/14/22 Stifel
Stifel keeps Buy rating on Applied Genetic, lowers price target to $10
09/24/21 Roth Capital
Applied Genetic near-term readouts 'major catalysts,' says Roth Capital
07/09/21 Chardan
Applied Genetic coverage transferred at Chardan
BAYRY Bayer
$16.04 /

+0.23 (+1.45%)

04/25/22 Morgan Stanley
Bayer price target raised to EUR 83 from EUR 77 at Morgan Stanley
04/05/22 Barclays
Bayer upgraded to Overweight from Equal Weight at Barclays
03/15/22 Barclays
Bayer price target raised to EUR 60 from EUR 55 at Barclays
03/14/22 Jefferies
Bayer initiated with a Buy at Jefferies
BMRN BioMarin
$83.49 /

+0.18 (+0.22%)

04/28/22 Wedbush
BioMarin price target lowered to $147 from $155 at Wedbush
04/25/22 Morgan Stanley
BioMarin upgraded to Overweight from Equal Weight at Morgan Stanley
02/24/22 Piper Sandler
BioMarin price target raised to $125 from $121 at Piper Sandler
01/10/22 JPMorgan
JPMorgan bullish on BioMarin following CEO 'encouraging' presentation
CE Celanese
$150.37 /

+4.53 (+3.11%)

04/13/22 Fermium Research
DuPont price target lowered to $78 from $87 at Fermium Research
04/08/22 JPMorgan
Celanese added to Analyst Focus List at JPMorgan
02/22/22 Deutsche Bank
Celanese likely to split-up in 2024 or 2025, says Deutsche Bank
02/22/22 Piper Sandler
Celanese downgraded to Underweight from Neutral at Piper Sandler
CELU Celularity
$11.38 /

-0.28 (-2.40%)

04/06/22 Truist
Celularity downgraded to Hold from Buy at Truist
04/01/22 Oppenheimer
Celularity price target raised to $10 from $9 at Oppenheimer
01/27/22 Oppenheimer
Celularity initiated with an Outperform at Oppenheimer
11/24/21 Morgan Stanley
Celularity initiated with an Equal Weight at Morgan Stanley
DNA Ginkgo Bioworks
$3.23 /

+0.105 (+3.36%)

03/31/22 BTIG
Ginkgo Bioworks price target lowered to $6 from $12 at BTIG
03/29/22 Cowen
Ginkgo Bioworks weakness a buying opportunity, says Cowen
03/02/22 Cowen
Ginkgo Bioworks initiated with an Outperform at Cowen
02/23/22 Goldman Sachs
Ginkgo Bioworks initiated with a Neutral at Goldman Sachs
EDIT Editas Medicine
$14.18 /

-0.1 (-0.70%)

04/18/22 Baird
Editas Medicine price target lowered to $33 from $44 at Baird
02/25/22 SVB Leerink
Editas Medicine price target lowered to $27 from $41 at SVB Leerink
02/25/22 Barclays
Editas Medicine price target lowered to $18 from $39 at Barclays
02/25/22 Chardan
Editas Medicine price target lowered to $60 from $75 at Chardan
HZNP Horizon Therapeutics
$94.70 /

-3.375 (-3.44%)

03/14/22 Oppenheimer
Horizon Therapeutics initiated with an Outperform at Oppenheimer
01/26/22 Piper Sandler
Horizon Therapeutics price target lowered to $133 from $143 at Piper Sandler
01/18/22 JPMorgan
Horizon Therapeutics valuation 'compelling' after selloff, says JPMorgan
12/08/21
Fly Intel: Top five analyst initiations
JNJ Johnson & Johnson
$178.28 /

-0.37 (-0.21%)

04/29/22 Chardan
Emergent BioSolutions price target lowered to $65 from $75 at Chardan
04/20/22 Credit Suisse
Johnson & Johnson price target raised to $205 from $200 at Credit Suisse
04/20/22 Citi
Johnson & Johnson price target raised to $210 from $203 at Citi
04/19/22 Stifel
J&J notes more-positive Q1 trends, U.S. Spine 'a relative outlier,' says Stifel
KALA Kala Pharmaceuticals
/

+

03/30/22 Northland
Kala Pharmaceuticals price target lowered to $4 from $6 at Northland
03/30/22 H.C. Wainwright
Kala Pharmaceuticals price target lowered to $6 from $9 at H.C. Wainwright
03/30/22 JPMorgan
Kala Pharmaceuticals downgraded to Underweight from Neutral at JPMorgan
12/15/21 Wedbush
Kala Pharmaceuticals assumed with an Outperform, $6 target at Wedbush
KOD Kodiak Sciences
$6.39 /

-0.065 (-1.01%)

04/13/22 Truist
Kodiak Sciences price target lowered to $10 from $35 at Truist
03/29/22 Chardan
Kodiak Sciences price target lowered to $19 from $82.50 at Chardan
02/28/22 Roth Capital
Kodiak Sciences price target lowered to $75 from $149 at Roth Capital
02/24/22 Truist
Kodiak Sciences price target lowered to $35 from $147 at Truist
LCTX Lineage Cell Therapeutics
$1.27 /

+0.065 (+5.39%)

04/25/22 H.C. Wainwright
Lineage Cell's PNC program 'an expected and logical move,' says H.C. Wainwright
08/19/21 Noble Capital
Lineage Cell Therapeutics initiated with an Outperform at Noble Capital
PRQR ProQR Therapeutics
/

+

04/19/22 Cantor Fitzgerald
ProQR Therapeutics price target lowered to $3.50 from $6.00 at Cantor Fitzgerald
04/14/22 Chardan
ProQR Therapeutics price target lowered to $2.50 from $8 at Chardan
03/15/22 Citi
ProQR Therapeutics price target lowered to $1 from $1.70 at Citi
02/14/22 Citi
ProQR Therapeutics downgraded to Neutral from Buy at Citi
REGN Regeneron
$660.09 /

+7.73 (+1.18%)

04/20/22 Cowen
Regeneron price target raised to $645 from $640 at Cowen
04/20/22 BTIG
Checkmate Pharmaceuticals downgraded to Neutral from Buy at BTIG
04/19/22 Baird
Decibel could be next target for Regeneron, says Baird
04/12/22 Barclays
Regeneron price target raised to $745 from $700 at Barclays
RGNX Regenxbio
$28.25 /

-0.15 (-0.53%)

03/29/22 Chardan
Regenxbio price target lowered to $76 from $90 at Chardan
02/10/22 SVB Leerink
Regenxbio price target lowered to $29 from $35 at SVB Leerink
12/15/21
Fly Intel: Top five analyst initiations
12/15/21 Wedbush
Wedbush initiates Regenxbio with a Neutral rating, price target of $29
RHHBY Roche
$45.13 /

-0.37 (-0.81%)

05/03/22 Piper Sandler
Piper keeps Overweight rating on Ionis after Biogen's Spinraza beat
04/26/22 Stifel
Arvinas price target lowered to $85 from $93 at Stifel
04/19/22 UBS
Roche downgraded to Sell from Neutral at UBS
STOK Stoke Therapeutics
$14.77 /

-0.21 (-1.40%)

01/31/22 Jefferies
Stoke Therapeutics initiated with a Buy at Jefferies
12/03/21
Fly Intel: Top five analyst initiations
12/03/21 BofA
Stoke Therapeutics initiated with a Buy at BofA
12/03/21 BofA
Stoke Therapeutics initiated with a Buy at BofA
UBX Unity Biotechnology
/

+

01/04/22 Roth Capital
Unity Biotechnology upgraded to Buy at Roth Capital on 2022 clinical plans
01/04/22 Roth Capital
Unity Biotechnology upgraded to Buy from Neutral at Roth Capital
12/15/21 Wedbush
Wedbush bullish on Unity Biotechnology, initiates with an Outperform
12/15/21 Wedbush
Unity Biotechnology assumed with an Outperform at Wedbush
UBX Unity Biotechnology
/

+

STOK Stoke Therapeutics
$14.77 /

-0.21 (-1.40%)

RHHBY Roche
$45.13 /

-0.37 (-0.81%)

RGNX Regenxbio
$28.25 /

-0.15 (-0.53%)

REGN Regeneron
$660.09 /

+7.73 (+1.18%)

PRQR ProQR Therapeutics
/

+

LCTX Lineage Cell Therapeutics
$1.27 /

+0.065 (+5.39%)

KOD Kodiak Sciences
$6.39 /

-0.065 (-1.01%)

KALA Kala Pharmaceuticals
/

+

JNJ Johnson & Johnson
$178.28 /

-0.37 (-0.21%)

HZNP Horizon Therapeutics
$94.70 /

-3.375 (-3.44%)

EDIT Editas Medicine
$14.18 /

-0.1 (-0.70%)

DNA Ginkgo Bioworks
$3.23 /

+0.105 (+3.36%)

CELU Celularity
$11.38 /

-0.28 (-2.40%)

CE Celanese
$150.37 /

+4.53 (+3.11%)

BMRN BioMarin
$83.49 /

+0.18 (+0.22%)

BAYRY Bayer
$16.04 /

+0.23 (+1.45%)

AGTC Applied Genetic
/

+

AERI Aerie Pharmaceuticals
$7.96 /

+0.47 (+6.28%)

ADVM Adverum Biotechnologies
$1.15 /

+0.03 (+2.69%)

ABEO Abeona Therapeutics
/

+

ABBV AbbVie
$149.61 /

+1.74 (+1.18%)

  • 22
    Mar
  • 17
    Dec
RHHBY Roche
$45.13 /

-0.37 (-0.81%)

REGN Regeneron
$660.09 /

+7.73 (+1.18%)

LCTX Lineage Cell Therapeutics
$1.27 /

+0.065 (+5.39%)

JNJ Johnson & Johnson
$178.28 /

-0.37 (-0.21%)

HZNP Horizon Therapeutics
$94.70 /

-3.375 (-3.44%)

CE Celanese
$150.37 /

+4.53 (+3.11%)

BAYRY Bayer
$16.04 /

+0.23 (+1.45%)

ABBV AbbVie
$149.61 /

+1.74 (+1.18%)

STOK Stoke Therapeutics
$14.77 /

-0.21 (-1.40%)

RHHBY Roche
$45.13 /

-0.37 (-0.81%)

RGNX Regenxbio
$28.25 /

-0.15 (-0.53%)

REGN Regeneron
$660.09 /

+7.73 (+1.18%)

PRQR ProQR Therapeutics
/

+

KOD Kodiak Sciences
$6.39 /

-0.065 (-1.01%)

JNJ Johnson & Johnson
$178.28 /

-0.37 (-0.21%)

HZNP Horizon Therapeutics
$94.70 /

-3.375 (-3.44%)

EDIT Editas Medicine
$14.18 /

-0.1 (-0.70%)

DNA Ginkgo Bioworks
$3.23 /

+0.105 (+3.36%)

CELU Celularity
$11.38 /

-0.28 (-2.40%)

CE Celanese
$150.37 /

+4.53 (+3.11%)

BMRN BioMarin
$83.49 /

+0.18 (+0.22%)

AGTC Applied Genetic
/

+

AERI Aerie Pharmaceuticals
$7.96 /

+0.47 (+6.28%)

ABBV AbbVie
$149.61 /

+1.74 (+1.18%)

KALA Kala Pharmaceuticals
/

+

JNJ Johnson & Johnson
$178.28 /

-0.37 (-0.21%)

DNA Ginkgo Bioworks
$3.23 /

+0.105 (+3.36%)

CELU Celularity
$11.38 /

-0.28 (-2.40%)

CE Celanese
$150.37 /

+4.53 (+3.11%)

ABBV AbbVie
$149.61 /

+1.74 (+1.18%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.